MedTrace Logo

Passiflora Extract for Benzodiazepine Withdrawal

NCT03780595 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 108

Last updated 2018-12-19

No results posted yet for this study

Summary

The aim of this clinical trials is compare the percentage of patient who achieve a reduction equal to or greater than 50% in the dose of benzodiazepines at 10 weeks of treatment.

Conditions

  • Benzodiazepine Withdrawal (Disorder)

Interventions

DRUG

Passiflora incarnata

Passiflora pills administration up to 6 pills per day

DRUG

Control

Control pills administration up to 6 pills per day

Sponsors & Collaborators

  • Nutricion Medica S.L.

    lead INDUSTRY

Principal Investigators

  • Luis Fernando Agüera · Hospital Universitario 12 de Octubre

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-27
Primary Completion
2019-06-30
Completion
2019-12-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03780595 on ClinicalTrials.gov